glp-1 obesity drug news today october 2025 The Obesity-Drug Revolution Is Stalling Beyond GLP-1: the next wave

Carl, A., Faber, J., Steffensen, R., Laurberg, P

As biofilms are a major problem in medical and industrial settings, for example by forming on catheters or on gallstones, there is a need for the identification and development of biofilm inhibitors 4,5,6

Readers who want to avoid needles altogether should ask a provider specifically about the oral semaglutide option that GoodRx lists under the Wegovy name, since a pill form sidesteps the injection routine without abandoning the same GLP-1 mechanism

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements, Biomolecules Vol